Brief: Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
01/05/2024 13:34
May 1 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS AND PEAK BIO ANNOUNCE PORTFOLIO
PRIORITIZATION PLAN FOR COMBINED GO-FORWARD MERGER ENTITY
Source text for Eikon: ID:nGNXbGWRhQ
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Peak Bio
See all newsBrief: Akari Therapeutics Announces Shareholder Approval In Connection With Peak Bio Merger
Brief: Akari Therapeutics And Peak Bio Announce Portfolio Prioritization Plan For Combined Go-Forward Merger Entity
Brief: Peak Bio, Inc. Announces Up-Listing To Otcqb Market
Brief: Peak Bio Announces Its Application To Uplist To The Otcqb Venture Market
Brief: Peak Bio, Inc. Announces Amendment And Continued Access To Equity Line Of Up To $100 Million USD Via An Accelerated Common Stock Purchase Transaction With White Lion Capital